Oxycodone

Members of the Sackler family who own OxyContin maker Purdue Pharma must pay billions of dollars to settle a flood of lawsuits over the harms of opioids, in a new deal formally approved by a federal bankruptcy judge on Tuesday. The Sacklers must contribute up to $7 billion over 15…

(AP) — On Tuesday, a federal bankruptcy court judge gave the green light to Purdue Pharma’s strategy to resolve numerous lawsuits related to the opioid epidemic, marking a significant step in addressing the devastating impact of OxyContin. Judge Sean Lane of the U.S. Bankruptcy Court was expected to articulate his…

Please enable JS and disable any ad blocker Read More

NEW YORK (AP) — A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for thousands of victims of the epidemic. The deal overseen by U.S. Bankruptcy Judge Sean Lane…

NEW YORK – A momentous decision awaits as stakeholders from various corners of the nation convene in a bankruptcy court this Friday. Lawyers representing Purdue Pharma, the maker of OxyContin, along with the Sackler family and an extensive array of claimants — including cities, states, counties, Native American tribes, and…

NEW YORK -- Lawyers representing OxyContin maker Purdue Pharma, branches of the Sackler family that own it, cities, states, counties, Native American tribes, people with addiction and others across the U.S. are expected to deliver a nearly unanimous message for a bankruptcy court judge Friday: Approve a plan to settle…

OxyContin maker Purdue Pharma 's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will go before a judge Friday, potentially setting up votes on whether to accept it for local governments, people who became addicted to the drug and other groups. This month, 49 states…

McKinsey & Co has agreed to pay $650 million to resolve a U.S. Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how to boost sales, according to a Reuters report. The report said that McKinsey has entered into a five-year deferred…

The agreement by the maker of OxyContin to settle thousands of lawsuits over the harm done by opioids could help combat the overdose epidemic that the painkiller triggered. But that does not mean all the victims are satisfied. In exchange for giving up ownership of drug manufacturer Purdue Pharma and for contributing up to…

Painkiller, a new Netflix limited series, is the latest drama to tackle the opioid epidemic. Of course, 2021's Dopesick and 2022's All the Beauty and the Bloodshed have tackled the rise of Purdue Pharma, the Sackler family, and OxyContin addiction. But Painkiller might be most poignant of them all. Based…